reinstat neutral
invest today pave way bright futur initi outperform
let deceler explan forth heal begin
stori set psr benefit materi favor mix unfold
revenu remain pressur execut expens initi tp
estim deposit sweep growth reiter outperform
leav behind controversi look forward product-driven valu creation
weekli roundup year azur migrat sql win server data
futur nutrish look squish lower estim tp
june mail y/i continu largest mailer
manag outperform week medicaid enrol report
canadian integr
top question earn
guid downsid risk estim nam
statu non-u analyst us disclosur credit suiss seek busi compani cover research report result
investor awar firm may conflict interest could affect object report investor consid report
singl factor make invest decis
what price week earn
holt len suggest temper lt growth price ew
chew vet survey sustain posit anim health demand trend
evan weekli dose therapi
lean weekend
someth chew robot camera come tradit
strategi econom strategi
similar previou quarter earn growth expect stronger
domest orient name result robust economi well
greater cyclic exposur global expos compani
 market cap report result earn beaten
compani exceed bottom-lin estim compar
past year
expect revenu earn ep growth
respect ep pace assum typic beat rate remaind
although aggreg ep expect rise median compani expect
grow
today compani repres report result includ cadenc
design system zion bancorp
american top ep estim lower provis off-set higher reward fee
pickup market expens share fell
miss estim lower revenu oper margin higher tax
howev net flow came expect share fell
estim pickup oversea activ off-set domest weak
affirm busi outlook share fell
synchroni finl exceed project increas loan growth core loan loss
reserv howev net interest incom came lower share fell
state street revenu exceed ep forecast lower tax rate target
increas cost save off-set mount fee pressur share ralli
date product utc date dissemin utc
reinstat neutral
bottom line reinstat coverag neutral rate target price
increment posit bia stem evid stabil trend across us
pharmaceut suppli chain see relief eas gener deflat well
enhanc visibl across brand price inflat rebat paradigm said share
low march vs see limit room upsid acknowledg
drug price scrutini remain overhang elect cycl along potenti
headwind opioid litig specif less visibl around strategi
report structur associ disclosur continu obscur core busi growth also
contribut neutral view
price month
restrict neutral
anem rx volum stabil gener price accord iqvia data prescript
util trend remain lacklust volum declin modestli june qtd
ytd howev base analysi sell-sid asp gener fell may
qtd notabl improv previou double-digit deflationari trend recent
year price declin led lower gross profit dollar drug distributor importantli
meaning regulatori chang medicar part rebat paradigm seemingli halt also
valuat risk share current trade ev/ebitda histor
averag target price impli ev/ebitda multipl essenti
par drug distributor peer view adequ reflect enhanc visibl
drug price rebat dynam well aforement opioid competit capit
deploy risk increment visibl core oper perform improv
underli fundament would impetu turn posit stock meanwhil
deterior backdrop oner drug price environ opioid litig miscu
would drive downsid view
date product utc date dissemin utc
invest today pave way bright
futur initi outperform tp
favor industri driver support growth prospect lead
independ healthcar technolog platform offer comprehens suit softwar analyt
technology-en servic solut aim improv result across aspect
complex us healthcar ecosystem benefit favor system-wid
trend includ reduc unnecessari medic spend grow popul chronic ill
higher-risk patient increas adopt value-bas care model increas
consumer healthcar servic prolifer healthcar data
predict diversifi revenu support lt growth
predict highli diversifi revenu recur singl custom
repres greater averag tenur chng top custom year
attract oper profil allow target oper effici invest busi
ration underpin long-term growth target revenu
ebitda invest year revenu growth like remain
lt target howev expect effici acceler chng growth
attract profil drive quick de-lever estim net leverag
rel higher hcit peer howev expect appli strong
initi outperform rate pt tp base
ebitda estim roughli discount closest-compar cern current multipl
risk includ current invest yield desir result high leverag limit financi
date product utc date dissemin utc
price/cost move favor auto industri vol concern back
weaker global auto build moder industri growth reduc ep estimate
refinish result perform reflect solid price trend along
sluggish volume growth although expect modestli outperform latter price
 cost collect trend posit along steadi cost cut improv
macro inevit weigh result ep est go
respect prudent move reduc guidanc rang
esp buysid expect materi reduct sens rang
realist target bear slightli lower equat roughli ep buysid
expect number fall due auto weak primarili focus potenti
feel earn materi event expect share remain range-bound
refinish demonstr price power share gain vs sluggish vol view
refinish result solid though acknowledg core market volum sluggish
continu believ market-shar beneficiari due posit
key mso us well on-going consolid europ calib collis
opportun still present believ risk share abra rel immateri
potenti nice win overal clear perform margin
continu moder rise
auto oem coat continu plagu transport result key reason
weaker result deriv weaker auto build eu china modest risk
despit easi comp construct improv believ region
volum still act overhang along on-going headlin risk balanc
forecast auto vol respect cse price
date product utc date dissemin utc
price month
forward product-driven valu creation
event preview facebook result set releas juli
recalibr product-by-product model price target remain adj
ep vs prior
invest case expect mark begin facebook resources/capit
alloc focus product develop henc offens versu houseclean
defens point evid chang stanc instagram checkout elimin
transact friction mobil leav one app open anoth allow instagram
deliv highly-qualifi traffic merchant advertis turn lead
higher ad price greater sustain long-term revenu growth output arpu
libra announc invit increment regulatori scrutini view ultim
success failur materi invest thesi near term tactic
perspect check advertis suggest minim deceler us budget coupl
on-going headwind europ therefor maintain fx-neutral ad revenu growth
estim maintain outperform rate fb share base follow
point facebook abl drive long term revenu growth without materi lift ad
load near-to-medium-term growth driver includ instagram marketplac street
model continu underestim long-term monet potenti billion-us
properti like messeng whatsapp growth recoveri expect fb
signal result call
valuat dcf-base price target use wacc termin growth
rate slower-than-expect adopt facebook variou ad unit greater regulatori
oversight risk estim
date product utc date dissemin utc
price month
event base discuss present telemat compani ariti own
nauto commerci auto focus pioneer autonom drive tech
insur servic access rais ep est
rais tp ntm ep vs
polici call snapshot profit non-telemat polici
compar previou estimate telematics-bas polici profit loss
ratio vs average also estim pgr bundl polici becom larger proport
overal mix carri loss ratio point better averag polici risk higher
accid frequenc greater telemat competit expect follow item drive
new estim telemat profit
telemat user exhibit lower rate distract drive accid take
place lower speed severity/cost accid materi lower
initi estim major benefit telemat driver less accid prone due
lower mileag driver self-select theori still hold true today earli day
adopt howev weve learn driver use telemat monitor app exhibit
materi lower accid sever well phenomenon larg driven
collis take place lower speed believ directli correl telemat
driver less distract think one know one track insur know
phone use person less like engag distract drive behavior
distract driving-bas accid sever higher driver less time
react earlier year announc would add roll telematics-bas distract
drive algorithm onto exist platform big deal statist point
driver use phone drive lead phone distract caus
date product utc date dissemin utc
price month
gener expect earn line consensu across coverag univers
could see volatil commerci name includ
expect arikayc revenu exceed street expect cs vs
consensu arikayc launch month expect ad clariti
long-term launch trajectori area focu new patient start clariti
durat treatment patient do/do cultur convert first month
expect anoth in-lin quarter crysvita believ street gener
incorpor project strong launch thought sell-sid model still dispers
around rare revenu recognit i/ impact howev could see volatil
compani report updat data over-the-counter defici gene therapi
gene therapi gene therapi preview detail
parent remodulin revenu number focu get first glimps
gener affect franchis channel check cours second
quarter suggest impact minim physician prefer switch stabl patient
seemingli absenc payor pressur convert patient
model chang revis estim
date product utc date dissemin utc
futur nutrish look squish lower
estim tp
lower ep ep
account concern weak smucker pet food compani caus
compani miss revenu growth target versu
manag ep guidanc consensu also lower
target price
signific risk ainsworth pet busi sale expect smucker pet
divis grow fy compar manag expect close
ainsworth growth deceler signific deceler nielsen track data
nutrish brand growth rate ainsworth sale point competit pressur
buffalo mass channel risk inventori built high buffalo new
advertis spot directli target nutrish indic share smucker
view two brand target differ consum lack confid nutrish
brand plan extend cat treat segment difficult comparison
nutrish brand launch petsmart last year
fy appear back-half-weight street model manag guid
flat-to-down term ep follow-up convers manag tone
sound flat given time new product launch headwind
divestitur lost privat label pet busi put pressur compani
deliv strong back-half compens slow start
valuat new tp assum forward ev/ebitda
estim assum discount packag food peer line histor discount
heighten competit intens coffe pet food repres largest downsid risk
date product utc date dissemin utc
price month
sentiment us larg cap remain poor macro company-specif
overhang remain focu investor year-to-d ibb xbi
under-perform ytd view investor remain concern drug
price growth recent phase failur recent decis trump administr
keep statu quo medicar part rebat fulli resolv concern drug price
reform focu shift may shift reimburs part also key legal
overhang particularli on-going lawsuit novartis/sandoz enbrel
ipr file regard tecfidera ip district court expect day compani
manag guid rule altern could see settlement
backdrop drug price legal overhang regard ip see
continu neg sentiment sector still recent gilead/ galapago deal
allergan deal transact continu could help revers sentiment trend
remaind overal think result across name fine result
typic better although highlight area name could stronger vertex
neurocrin weaker regeneron
discuss view sector go earn host call
increas would like improv sentiment reflect larg
cap pharma deal year gilead galapago deal help recharg interest
investor may sit round gilead believ compani becom
interest stori overal continu posit sector look evid
increas focu especi gilead
vertex neurocrin well pois ahead quarter vertex project higher ep
compar factset consensu averag revenu cs vs
continu believ guidanc conserv beatabl neurocrin could
beat ingrezza revenu given downbeat sentiment
regeneron could face challeng quarter project lower
revenu compar consensu ms sma headwind high-
impact catalyst buy-back could help ep benefit like short-liv beyond
could challeng achiev meaning growth without larg scale
deal look regeneron continu believ current consensu expect
sanofi partnership high may contribut anoth revenu miss
chang tp regeneron well updat ep estim
gilead regeneron
date product utc date dissemin utc
pleas see detail earn preview
battl busi modelsportfolio play win clear diverg
stock perform overal multipl re-rat group led self-help portfolio
optim name like jec rel tradit player like
mdr outperform recent announc plan mid-jun
spin manag servic segment order re-rat busi
govern servic play believ question focu detail spin
whether announc actual result put asset play believ
mute expect potenti proce expect divestitur part
construct servic busi particular cycl concern lastli expect good
amount focu abil grow margin core busi achiev target
given catch-up requir offer investor best world
good organ growth opportun govern segment
focus growth target laid analyst day impli
earn obvious complet ichthi project abil de-lev balanc sheet
topic well opportun unlock sharehold valu split energi
tradit cs put problem behind
interest earn call given recent chang c-level new cfo mike steuert back
command investor want know bad thing expect addit charg order
clean prior legaci issu well better understand health exist portfolio
expect updat new ceo carlo hernandez helm past day
particular regard strateg initi invest like nuscal coeec joint
ventur stork well opportun de-risk portfolio streamlin cost
structur believ health balanc sheet becom topic along
cours updat abil re-negotiate/de-risk canada project
believ fair amount concern strateg review result major chang
underwhelm rel seen rest group mdr investor want
anoth quarter absent charg cameron freeport progress free cash flow
well believ mdr abil clean balanc sheet topic particular
grow concern time potenti proce asset sale obvious
commerci settlement sempra implic cameron topic along
plu award quarter impli ep trajectori go forward
specialti contractorsmor believ guid
reason base larg base/recur earn margin revenu upsid
assum secur larg project win howev stock re-rat believ
margin need improv level compar ep without larg project
less volatil order get credit recur busi model investor
need see ramp wirelin wireless spend requir invest ramp
intact secur known busi believ could soon outpac oil
ga term revenu ebtida contribut believ would re-rat multipl
compani view secular growth stori
updat estim updat estim well
increas target price
date product utc date dissemin utc
guid downsid risk
estim nam outlook
ep guid weak gener expect strong
deliv line ep vs cse/con though
signific miss vs cse/con driven drag vs rev
q/q guid better vs neutral impli
yield expect yield
divi reassur posit capital-expenditure comment may sinc
cover dividend call incom ceo le peuch voic commit
first ceo step back commit assuag investor concern
near-term divi sanctiti outgo ceo kibsgaard spoke capital-expenditure rev vs histor
con impli delta posit
environ investor focus
bring forecast lower nam outlook lower ep est
introduc estimate forecast assum
nam capital-expenditure continu high-single-digit int growth forecast
con suspect buysid alreadi anticip declin nam capital-expenditure
continu upper-single-digit int growth impli embed expect close
forecast lower pt impli ev/ebitda remain
remain neutral rate see well posit current outlook continu int
strength weak nam mrkt impli yield cse significantli
attract average less compel vs yield
date product utc date dissemin utc
price month
continu rate outperform rel tradit asset managersw covera
look firm continu gain share challeng backdrop industri also
believ firm ep growth re-acceler unusu factor pressur fee rate
subsid includ diverg beta fx securitieslend fee look blk strong organ
growth continu firm gener posit oper leverag
increas ep rais ep estim
due higher organ growth aum forecast partial off-set lower fee rate
tp increas base cash ep estim
impli total return risk stock includ futur diverg beta fx headwind
fee rate revers active-to passiv rotat migrat etf rel
record total flow ann organ growth gener record total flow
fix incom flow quarter bond flow broad-bas driven activ etf
index two larg strateg low-fe mandat win activ bond major
surpris also gener decent flow activ equiti driven quant busi
flow closed-end fund launch largest five year etf busi continu
gener strong stabl flow cash busi gener flow
largest cash manag world juli ishar see robust flow flow
note fix incom etf repres bond market
date product utc date dissemin utc
price month
let deceler explan forth
heal begin
event preview alphabet result compani report juli
adj ep estim vs prior target price
remain
invest case closer understand factor drove googl
revenu deceler supersed investor focu away hope would
resumpt compani reiter conduct liter hundr
chang product chang may transitori other
lap market live late may note googl announc multitud
product could skew revenu growth higher lower advertis adopt
new ad products/unit typic tend pick sometim brace
may like increment near-term headwind effort self-regul around
user privaci henc invest perspect choos look across may
near-term valley view long-term opportun maintain outperform rate
expect aforement develop serv valid invest thesi
remain root follow on-going monet improv search
product updat larger-than-expect contribut googl larger non-search
busi option valu creation new monet initi map
well eventu commerci googl bet waymo life scienc
valuat dcf-deriv price target use weight averag cost capit
termin growth rate continu suggest slower-than-expect advertis
adopt googl new ad unit risk price target estim
date product utc date dissemin utc
price month
stori set psr benefit
materi favor mix unfold
conclus follow noisi week within transport sector believ investor
gener happi ksu result despit lower volum outlook consist
weve heard class peer compani maintain revenu growth
guid mainli due expect favor mix specif expect see growth
higher rpu segment chemic petroleum ag miner outpac lower rpu
intermod owe softer tl market perhap even importantli compani
note expect achiev low end rang
driven increas psr-relat cost save vs prior given better servic
perform improv across key metric train length car miles/day etc
confid execut target point
revenu guidanc intact slightli better guid lower expect capital-expenditure spend
stand gener substanti go forward believ move
stock friday justifi continu see upsid maintain outperform
rais estim tp rais ep estim
respect estim rise tp
increas owe higher base year ebit lower discount rate
risk includ unfavor trade polici weaker-than-expect volum growth
date product utc date dissemin utc
price month
expens initi tp
state street report ep ex item cs consensu
revenu essenti line clear expect materi
reduc report expens bit forecast lower share count lower tax rate
benefit result fee revenu pressur quarter wors anticip fact
moder recent extraordinari level manag seem intent realiz
target expens save latter could take edg reduc nii expect
estim unchang per share trim estim
reduc nii expect flow factor lower view dcf model
take target price risk earn target price realiz tie
macro factor level short-term interest rate market valu volum flows/mix
chang competit landscap price pressur execut abil drive
sustain oper leverag realiz acquisit synergi
quick take second-quart highlight respect price pressur
moder organiz chang manag price negoti /client profit
accomplish three quarter expect repric wave posit ii good new
busi momentum aum net inflow posit quantiti qualiti larg long-term
institut iii gross new servic commit pipelin new busi
instal vs iv headcount downsustain effici realiz
critic lowlight asset custodi flattish nim/nii pressur way
date product utc date dissemin utc
price month
estim deposit sweep growth
continu rate outperform look breakaway broker theme institut
channel discount broker theme retail channel help support strong organ growth
st basi pull back expens growth guidanc
lower expect firm proactiv lower expens growth help off-set
softer revenu addit forecast re-acceler capit return via dividend
increas share buyback given complet bulk transfer effort current
trade versu histor averag forecast
client cash sort continu slow client cash net flow posit june
juli schw recent client cash activ suggest inflect point could
horizon ytd sort trend slow exclud april tax season go forward
estim pace client cash sort continu decreas schw interest-earn
asset balanc end roughli flat level client cash alloc could
close cyclic trough continu see client re-risk potenti risk balanc sheet
growth off-set cash gener schw net new asset
increas ep target price increas ep estim
base slightli higher interest-earn asset assumpt driven lower
client cash sort higher net new asset assumpt accordingli rais target
price use multipl ep estim risk stock
includ invert yield curv impact asset yield futur price cut
although see risk equiti rack rate low addit declin client cash
sweep balanc client sort transact cash away invest cash
date product utc date dissemin utc
price month
earlier week report earn per share put core earn
item detail herein thu cent better estim term
forward look visibl remain challeng guidanc upper end expens rang
flat expens level wasnt terribl surprisingthi
singl biggest driver estim revis believ point
oper meaning improv effici timet realiz unclear
spend complianc risk manag understand priorit displac
expens initi pend ceo search compromis visibl estim
oper ep per share respect target price
unchang risk achiev estim target price tie
macro level econom activ yield curv loan demand credit qualiti migrat
health capit market micro earn visibl compromis
stock wait share price out-performance reli confid
sustain growth roe prospect latter compromis consent order pend
leadership chang believ bank stock hold pattern new ceo
place maintain neutral rate wait assess stock risk/reward profil
former tie extend estim risk latter reflect valu inher well fargo
price month
date product utc date dissemin utc
weekli roundup year azur migrat
inspir year azur cloud migrat gavriella schuster
judson althoff preview compani prioriti area identifi six area focu
partner azur migrat powerapp dynam ai ms
schuster dub year azur cloud migrat cite cloud market today
total address market announc azur migrat program help
custom acceler journey cloud azur lighthous enabl partner
manag azur scale across custom also disclos azur marketplac
applic servic transact month
window server sql server opportun server instal base still
window server sql server approxim million instanc
size total opportun partner billion market opportun
go right year believ end-of-lif sql server window
server juli januari respect drive server product strength
offic smb opportun inspir smb opportun size
custom worth offic less
microsoft team microsoft team trajectori compar sharepoint decad ago
mani rememb explos growth sharepoint decad ago
alreadi faster trajectori
date product utc date dissemin utc
price month
dental practic volum revenu growth better trend accord
proprietari survey us dental practition practic experienc posit revenu
growth rise weight average nice improv survey new
patient traffic meaning driver practic revenu follow
orthodont routin visit bridg implant respond
remain optimist ntm trend expect improv practic volum vs
trend indic meaning turnaround dental demand modestli
encourag stabil provid baromet perform across dental coverag
univers note key caveat fourth quarterli survey expect increasingli
relev takeaway greater histor context survey slightli skew
toward orthodontist latest quarter rel prior mix experi
equipmentdigit dentistri driver innov respond seemingli
sequenti upbeat equip purchas next twelv month particular
focu intraor scanner note practition may still remain wari larger cash
outlay light macro concern well note reimburs pressur maintain
posit thesi amidst longer term turnaround stori innov
seemingli materi new primescan offer suresmil clear align system
softwar said traction primescan admittedli earli day respond
current util system expect immin purchas system
await upgrad cycl acknowledg element pent demand xray suresmil
broadli experienc posit review await commentari xray opportun
market similarli encourag traction
itero offer remain strong albeit potenti driven notabl higher promot activ survey
suppli chain direct dist amazon updat neutral patterson
compani outperform name primari distributor
respond respect vast major satisfi primari distributor
work gpo unsurpris dynam differ meaning anim
market standard medic consum glove cotton ball
purchas amazon today respond expect purchas amazon could grow
year term direct distribut respond current purchas
consum equip direct manufactur respond
expect purchas consum equip respect directli next twelv
month trend may continu dental manufactur invest intern sale
clear align remain focusalign domin major clear align user
expect demand rise ntm larg driven market effort major compani
volum also support rise base train practition alignsinvisalign remain
clear market leader cohort current util offer clear align
user offer invisalign case treat algn comprehens invisalign
full offer though continu await traction invisalign go mandibular
advanc remain well ahead term innov practition
seemingli worri dtc concept gain traction marketplac other view
greater market effort around clear align solut may drive accept solut
broadli therebi benefit doctor-direct market well concern competit
dtc concept remain overhang view room sever player
highli under-penetrated clear align market well ahead term innov
await traction recent launch product
date product utc date dissemin utc
thought usual busi week brookfield group two major event
close brookfield infrastructur partner lp bip common equiti offer
address note reinstat coverag neutral rate target price
oecd expans simpli equiti offer help replenish balanc sheet ampl
activ came way relianc industri announc brookfield confirm
 bip look involv indian telecom tower deal relianc per note
transact time take tower long await indian acquisit
transact note saga surround potenti capit invest indian tower sector
circul media sourc number year announc actual deal
view posit provid context recent equiti rais along
potenti deal pipelin number busi group
stub movement week bam stub follow
attribut bbu bep bip bpi
compon
date product utc date dissemin utc
earn impli move option impli
averag move reaction result essenti in-lin averag move
share seen past four report past ten quarterli report
compani result like in-lin believ addit disclosur lack
